Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evelyne Doudnikoff

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Scientific Reports|May 26, 2017
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesiaMatthieu F Bastide, Christelle Glangetas, Evelyne Doudnikoff, et al.
Biological Psychiatry|December 3, 2014
Inhibiting Lateral Habenula Improves L-DOPA-Induced DyskinesiaMatthieu F Bastide, Brice de la Crompe, Evelyne Doudnikoff, et al.
Journal of Cellular Biochemistry|April 13, 2016
CD154 Induces Matrix Metalloproteinase-9 Secretion in Human PodocytesClaire Rigothier, Richard Daculsi, Sébastien Lepreux, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
Frontiers in Aging Neuroscience|October 14, 2014
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?Giselle Charron, Evelyne Doudnikoff, Marie-Helene Canron, et al.
Neurobiology of Disease|March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassemblyPedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
Biological Psychiatry|October 25, 2008
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesiaStefan Schuster, Evelyne Doudnikoff, Daniella Rylander, et al.
JCI Insight|August 23, 2019
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathiesMarie-Laure Arotcarena, Mathieu Bourdenx, Nathalie Dutheil, et al.
Plos One|February 14, 2008
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposureBirger Scholz, Marcus Svensson, Henrik Alm, et al.
Nature Communications|July 12, 2020
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodelingFederico N Soria, Chiara Paviolo, Evelyne Doudnikoff, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|May 26, 2017
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesiaMatthieu F Bastide, Christelle Glangetas, Evelyne Doudnikoff, et al.
Biological Psychiatry|December 3, 2014
Inhibiting Lateral Habenula Improves L-DOPA-Induced DyskinesiaMatthieu F Bastide, Brice de la Crompe, Evelyne Doudnikoff, et al.
Journal of Cellular Biochemistry|April 13, 2016
CD154 Induces Matrix Metalloproteinase-9 Secretion in Human PodocytesClaire Rigothier, Richard Daculsi, Sébastien Lepreux, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
Frontiers in Aging Neuroscience|October 14, 2014
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?Giselle Charron, Evelyne Doudnikoff, Marie-Helene Canron, et al.
Neurobiology of Disease|March 14, 2015
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassemblyPedro Barroso-Chinea, Marie-Laure Thiolat, Simone Bido, et al.
Biological Psychiatry|October 25, 2008
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesiaStefan Schuster, Evelyne Doudnikoff, Daniella Rylander, et al.
JCI Insight|August 23, 2019
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathiesMarie-Laure Arotcarena, Mathieu Bourdenx, Nathalie Dutheil, et al.
Plos One|February 14, 2008
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposureBirger Scholz, Marcus Svensson, Henrik Alm, et al.
Nature Communications|July 12, 2020
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodelingFederico N Soria, Chiara Paviolo, Evelyne Doudnikoff, et al.
Pageof 4